Elevated bilirubin levels are associated with a better renal prognosis and ameliorate kidney fibrosis
Open Access
- 22 February 2017
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 12 (2) , e0172434
Abstract
Bilirubin has been reported to protect against kidney injury. However, further studies highlighting the beneficial effects of bilirubin on renal fibrosis and chronic renal function decline are necessary. We assessed a prospective cohort with a reference range of total bilirubin levels. The primary outcome was a 30% reduction in the estimated glomerular filtration rate (eGFR) from baseline, and the secondary outcome was a doubling of the serum creatinine levels, halving of the eGFR and the initiation of dialysis. In addition, experiments with tubular epithelial cells and C57BL/6 mice were performed to investigate the protective effects of bilirubin on kidney fibrosis. As a result, 1,080 patients were included in the study cohort. The study group with relative hyperbilirubinemia (total bilirubin 0.8–1.2 mg/dL) showed a better prognosis in terms of the primary outcome (adjusted hazard ratio (HR) 0.33, 95% confidence interval (CI) 0.19–0.59, P < 0.001) and the secondary outcome (adjusted HR 0.20, 95% CI 0.05 to 0.71, P = 0.01) than that of the control group. Moreover, the bilirubin-treated mice showed less fibrosis in the unilateral ureteral obstruction (UUO) model (P < 0.05). In addition, bilirubin treatment decreased fibronectin expression in tubular epithelial cells in a dose-dependent manner (P < 0.05). Mildly elevated serum bilirubin levels were associated with better renal prognosis, and bilirubin treatment induced a beneficial effect on renal fibrosis. Therefore, bilirubin could be a potential therapeutic target to delay fibrosis-related kidney disease progression.Keywords
Funding Information
- National Research Foundation of Korea (KR) (2015R1C1A1A01055717)
- Korean Society of Nephrology
This publication has 32 references indexed in Scilit:
- Bilirubin attenuates the renal tubular injury by inhibition of oxidative stress and apoptosisBMC Nephrology, 2013
- Mechanisms of fibrosis: therapeutic translation for fibrotic diseaseNature Medicine, 2012
- Go Green: The Anti-Inflammatory Effects of Biliverdin ReductaseFrontiers in Pharmacology, 2012
- Serum Bilirubin Links UGT1A1*28 Polymorphism and Predicts Long-Term Cardiovascular Events and Mortality in Chronic Hemodialysis PatientsClinical Journal of the American Society of Nephrology, 2011
- Bilirubin Exerts Renoprotective Effects in Angiotensin II-HypertensionThe American Journal of the Medical Sciences, 2010
- New Insights into Epithelial-Mesenchymal Transition in Kidney FibrosisJournal of the American Society of Nephrology, 2010
- The Mildly Elevated Serum Bilirubin Level is Negatively Associated with the Incidence of End Stage Renal Disease in Patients with IgA NephropathyJournal of Korean Medical Science, 2009
- Overview of factors contributing to the pathophysiology of progressive renal diseaseKidney International, 2008
- Gilbert syndrome and ischemic heart disease: a protective effect of elevated bilirubin levelsAtherosclerosis, 2002
- Quality of Life of Patients with End-Stage Renal DiseaseNew England Journal of Medicine, 1985